Microwave ablation with chemoembolization for large hepatocellular carcinoma in patients with cirrhosis

References

• IARC. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013 [cited 2014 Oct 21]. Available at: http://globocan.iarc.fr
   Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917.
   PubMed Web of Science ®Google Scholar
• Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–458.
   PubMed Web of Science ®Google Scholar
• Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–524.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
   PubMed Web of Science ®Google Scholar
• Shindoh J, D Tzeng CW, Vauthey JN. Portal vein embolization for hepatocellular carcinoma. Liver Cancer. 2012;1:159–167.
   PubMed Web of Science ®Google Scholar
• Poggi G, Montagna B, DI Cesare P, et al. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res. 2013;33:1221–1227.
   PubMed Web of Science ®Google Scholar
• Yu NC, Raman SS, Kim YJ, et al. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol. 2008;19:1087–1092.
   PubMed Web of Science ®Google Scholar
• Brace CL. Dual-slot antennas for microwave tissue heating: parametric design analysis and experimental validation. Med Phys. 2011;38:4232–4240.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37:429–442.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bru ´ C, Bruix J, et al. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329–338.
   PubMed Web of Science ®Google Scholar
• Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461–469.
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma or 4 cm. Gastroenterology. 2004;127:1714–1723.
   PubMed Web of Science ®Google Scholar
• Sturm JW, Keese M, et al. Multimodal treatment of hepatocellular carcinoma (HCC). Onkologie. 2004;27:294–303.
   PubMedGoogle Scholar
• Yin XY, Xie XY, Lu MD, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer. 2009;115:1914–1923.
   PubMed Web of Science ®Google Scholar
• Takaki H, Yamakado K, Uraki J, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol. 2009;20:217–224.
   PubMed Web of Science ®Google Scholar
• Si ZM, Wang GZ, Qian S, et al. Combination therapies in the management of large (≥5 cm) hepatocellular carcinoma: microwave ablation immediately followed by transarterial chemoembolization. J Vasc Interv Radiol. 2016;27:1577–1583.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Lee YH, Hsia CY, et al. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology. 2013;57:112–119.
   PubMed Web of Science ®Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Hasegawa K, Aoki T. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–1916.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235:728–739.
   PubMed Web of Science ®Google Scholar
• Cardella JF, Kundu S, Miller DL, Society of Interventional Radiology, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20(7 Suppl):S189–S191.
   Web of Science ®Google Scholar
• Saviano A, Iezzi R, Giuliante F, et al. Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28:1512–1519.
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–432.
   PubMed Web of Science ®Google Scholar
• Takuma Y, Takabatake H, Morimoto Y, et al. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology. 2013;269:927–937.
   PubMed Web of Science ®Google Scholar
• Luo J, Peng ZW, Guo RP, et al. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. Radiology. 2011;259:286–295.
   PubMed Web of Science ®Google Scholar
• Yoon HM, Kim JH, Kim EJ, et al. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. J Vasc Interv Radiol. 2013;24:1639–1646.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol. 1998;9:101–111.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Kikuchi M, Okazaki M, et al. Hepatocellular carcinoma after transcatheter hepatic arterial embolization: a histopathologic study of 84 resected cases. Cancer. 1994;73:2259–2267.
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology. 2009;251:933–940.
   PubMed Web of Science ®Google Scholar
• Abdelaziz AO, Nabeel MM, Elbaz TM, et al. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis. Scand J Gastroenterol. 2015;50:479–484.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen Q, Wang N, et al. Percutaneous microwave ablation of 5-6 cm unresectable hepatocellular carcinoma: local efficacy and long-term outcomes. Int J Hyperthermia. 2016;247–254.
   Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, International Working Group on Image-guided Tumor Ablation, and Interventional Oncology Sans Frontières Expert Panel, and Technology Assessment Committee of the Society of Interventional Radiology, and Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe, et al. Imageguided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Jin YJ, Lee JW, Choi YJ, et al. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. J Gastrointest Surg. 2014;18:555–561.
   PubMed Web of Science ®Google Scholar
• Chang YJ, Chung KP, Chang YJ, et al. Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas. Br J Surg. 2016;103:1513–1520.
   PubMed Web of Science ®Google Scholar